drugset
drugset / Trial / NCT04831736

Effect of Postoperative Single Dose of Ketamine on Pain After Mastectomy

NCT04831736 ↗

Phase 4 Completed 31 enrolled NYU Langone Health
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a randomized, single blinded, placebo-controlled trial to study the effectiveness of a subanesthetic dose (0.6mg/kg) of ketamine versus placebo (saline) on postoperative pain on adult women undergoing mastectomy. The objective of the study is to examine the effect of a subanesthetic dose (0.6mg/kg) of ketamine vs. saline control on postoperative pain in subjects who have undergone mastectomy.

Timeline

Start
2021-04-26
Primary completion
2022-03-29
Completion
2022-03-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.6 mg/kg Intravenous

Indications

No indication recorded.